http://medicineworld.org/cancer/breast/breast-cancer-blog.html Breast cancer blog from medicineworld.org adds a personal touch to the stories related to breast cancer. This breast cancer blog brings you stories of hope, stories of survivors and latest news and research related to breast cancer. Thu, 19 Jun 2008 03:02:38 GMT en-us http://medicineworld.org/images/breast-cancer-blog.jpg http://medicineworld.org/cancer/blog/permalinks/Dec-2005/cure-cancer-with-your-personal-computer.html 121 90 http://medicineworld.org/cancer/lead/6-2008/understanding-of-cell-behaviour-in-breast-cancer.html http://medicineworld.org/cancer/lead/6-2008/understanding-of-cell-behaviour-in-breast-cancer.html Thu, 19 Jun 2008 03:02:38 GMT The invasion and spread of cancer cells to other parts of the body, known as metastasis, is a principal cause of death in patients diagnosed with breast cancer. Eventhough patients with early stage, small, breast tumours have an excellent short term prognosis, more than 15 to 20 per cent of them will eventually develop distant metastases, and die from the disease. Vascular invasion - through lymphatic and blood vessels - is the major route for cancer spreading to regional lymph nodes and to the rest of the body........ ]]> http://medicineworld.org/cancer/lead/6-2008/raloxifene-breast-cancer.html http://medicineworld.org/cancer/lead/6-2008/raloxifene-breast-cancer.html Thu, 19 Jun 2008 03:02:38 GMT Women who took raloxifene were less likely to develop invasive estrogen-receptor (ER) positive breast cancer compared with women who did not, as per data from a randomized controlled trial published online June 10 in the Journal of the National Cancer Institute The drug did not reduce the risk of non-invasive cancer or invasive ER-negative cancers........ ]]> http://medicineworld.org/cancer/lead/5-2008/deceptive-high-risk-breast-tumors.html http://medicineworld.org/cancer/lead/5-2008/deceptive-high-risk-breast-tumors.html Thu, 19 Jun 2008 03:02:38 GMT A unique genetic signature can alert physicians to high-risk breast tumors that are masquerading as low-risk tumors, as per research at Washington University School of Medicine in St. Louis and collaborating institutions. Eventhough these tumors are apparently estrogen-receptor positive meaning they should depend on estrogen to grow they don't respond well to anti-estrogen treatment........ ]]> http://medicineworld.org/cancer/lead/5-2008/link-between-vitamin-d-status-breast-cancer.html http://medicineworld.org/cancer/lead/5-2008/link-between-vitamin-d-status-breast-cancer.html Thu, 19 Jun 2008 03:02:38 GMT Using newly available data on worldwide cancer incidence, scientists at the Moores Cancer Center at University of California, San Diego (UCSD) and the Department of Family and Preventive Medicine have shown a clear association between deficiency in exposure to sunlight, specifically ultraviolet B (UVB), and breast cancer........ ]]> http://medicineworld.org/cancer/lead/5-2008/risk-for-developing-breast-cancer.html http://medicineworld.org/cancer/lead/5-2008/risk-for-developing-breast-cancer.html Thu, 19 Jun 2008 03:02:38 GMT A chemical reaction in genes that control breast cancer provides a molecular clock that could one day help scientists more accurately determine a woman's risk for developing breast cancer and provide a new approach for therapy, UT Southwestern Medical Center scientists have found. As per a research findings published in today's issue of Cancer Epidemiology Biomarkers and Prevention, researchers from UT Southwestern show that the chemical process, called methylation, is strongly correlated with breast-cancer risk and with premalignant changes in the breast cells........ ]]> http://medicineworld.org/cancer/lead/5-2008/adding-ultrasound-screening-to-mammography.html http://medicineworld.org/cancer/lead/5-2008/adding-ultrasound-screening-to-mammography.html Thu, 19 Jun 2008 03:02:38 GMT Adding a screening ultrasound examination to routine mammography reveals more breast cancers than mammography alone, as per results of a major new clinical trial. The trial, however, also observed that adding an ultrasound exam also increases the rate of false positive findings and unnecessary biopsies........ ]]> http://medicineworld.org/cancer/lead/5-2008/physical-activity-prevent-breast-cancer.html http://medicineworld.org/cancer/lead/5-2008/physical-activity-prevent-breast-cancer.html Thu, 19 Jun 2008 03:02:38 GMT Physically active women are 25 per cent less likely to get breast cancer, but certain groups are more likely to see these benefits than others, finds a review of research published online ahead of print in the British Journal of Sports Medicine. The type of activity undertaken, at what time in life and the womans body mass index (BMI) will determine how protective the activity is against the disease........ ]]> http://medicineworld.org/cancer/lead/5-2008/6-month-mammogram-follow-up.html http://medicineworld.org/cancer/lead/5-2008/6-month-mammogram-follow-up.html Thu, 19 Jun 2008 03:02:38 GMT Radiologists can, with confidence, recommend a six-month follow-up diagnostic mammogram rather than an immediate biopsy for patients with probably non-malignant breast lesions, a new study emphasizes. The study observed that six-month short-interval follow-up examinations had an 83% sensitivity, which is similar to the sensitivity of other diagnostic mammograms, said Erin J. Aiello Bowles, MPH, lead author of the study from the Group Health Center for Health Studies. High sensitivity means identifying a high proportion of true positives (actual cancer cases) and a low proportion of false negatives (cases mistakenly deemed benign)........ ]]> http://medicineworld.org/cancer/lead/4-2008/predicting-breast-cancer-patient-outcome.html http://medicineworld.org/cancer/lead/4-2008/predicting-breast-cancer-patient-outcome.html Thu, 19 Jun 2008 03:02:38 GMT Not a day goes by without a new story about the environment. Eventhough we often consider the environment on a global scale, cells in our body also have to contend with environmental factors. New studies from a team of scientists from the Research Institute of the MUHC and McGill University show that the environment surrounding breast cancer cells plays a crucial role in determining whether tumor cells grow and migrate or whether they fade away. Their study is the first to identify the genes behind this environmental control and correlate them with patient outcome. Their findings appear in this weeks issue of Nature Medicine........ ]]> http://medicineworld.org/cancer/lead/4-2008/advances-in-breast-reconstruction.html http://medicineworld.org/cancer/lead/4-2008/advances-in-breast-reconstruction.html Thu, 19 Jun 2008 03:02:38 GMT Lumpectomy or breast conservation surgery is the most common type of breast cancer surgery currently performed. A benefit of the surgery is that only part of the breast is removed, but a drawback can be the resulting physical appearance of the breast, which may be disfigured, dented or uneven. A report in April's Plastic and Reconstructive Surgeryandreg; , the official medical journal of the American Society of Plastic Surgeons (ASPS), examines advances plastic surgeons have made in breast reconstruction to repair the damage left when cancer is removed........ ]]> http://medicineworld.org/cancer/lead/4-2008/capecitabine-combo-produces-side-effects.html http://medicineworld.org/cancer/lead/4-2008/capecitabine-combo-produces-side-effects.html Thu, 19 Jun 2008 03:02:38 GMT Adding capecitabine, a drug that inhibits DNA synthesis and slows the growth of tumour tissue, to docetaxel, in patients with early breast cancer, leads to more toxicities and does not improve the efficacy of therapy, a German scientist told the 6th European Breast Cancer Conference (EBCC-6) today (Thursday 17 April). Previously, such a combination had improved patient survival in metastatic disease, where the cancer has spread to other parts of the body........ ]]> http://medicineworld.org/cancer/lead/4-2008/lapatinib-shrinks-breast-cancer-tumors.html http://medicineworld.org/cancer/lead/4-2008/lapatinib-shrinks-breast-cancer-tumors.html Thu, 19 Jun 2008 03:02:38 GMT A drug that targets the cell surface receptors that play an important role in a number of types of cancer can bring about significant tumour regression in breast cancer after only six weeks of use, a scientist told the 6th European Breast Cancer Conference (EBCC-6) today (Thursday 17 April). Dr. Angel Rodriguez, from the Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, USA, said that the work shown for the first time that the tyrosine kinase inhibitor lapatinib could decrease tumour-causing breast cancer stem cells in the primary breast cancers of women receiving neoadjuvant therapy (treatment given before the primary surgery for the disease)........ ]]> http://medicineworld.org/cancer/lead/4-2008/standard-chemo-against-brca2.html http://medicineworld.org/cancer/lead/4-2008/standard-chemo-against-brca2.html Thu, 19 Jun 2008 03:02:38 GMT The first study to investigate the effects of chemotherapy on metastatic breast cancer in women with the BRCA1 or BRCA2 gene mutation has shown that standard chemotherapy works better in these patients than in women without the BRCA1/2 mutation. The authors of a study presented today (Thursday) at the 6th European Breast Cancer Conference (EBCC-6) in Berlin observed that women with BRCA2-associated breast cancer had a significantly higher response rate, a longer time without the disease progressing, and a longer overall survival when treated with anthracycline-based regimens than did women with sporadic breast cancers that were not linked to BRCA1/2........ ]]> http://medicineworld.org/cancer/lead/4-2008/screening-mammography-in-elderly-patients.html http://medicineworld.org/cancer/lead/4-2008/screening-mammography-in-elderly-patients.html Thu, 19 Jun 2008 03:02:38 GMT Eventhough guidelines keep changing regarding screening mammography in elderly patients, those older than 70 years old continue to benefit from this exam, showing that with frequent mammograms breast cancers can be found sooner, as per a recent study conducted by scientists at Jacobi Medical Center and Albert Einstein College of Medicine, in Bronx, NY........ ]]> http://medicineworld.org/cancer/lead/4-2008/radiation-beneficial-breast-cancer.html http://medicineworld.org/cancer/lead/4-2008/radiation-beneficial-breast-cancer.html Thu, 19 Jun 2008 03:02:38 GMT A patients with breast cancer age alone should not determine whether or not she receives standard breast-conservation therapys, including a lumpectomy and radiation treatment; however, if additional health problems (comorbidities) are present, therapys should be individualized based on age and the type of comorbidities, as per a research studyin the April 1 edition of the International Journal for Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology........ ]]> http://medicineworld.org/cancer/lead/4-2008/protein-and-prognosis-in-breast-cancer.html http://medicineworld.org/cancer/lead/4-2008/protein-and-prognosis-in-breast-cancer.html Thu, 19 Jun 2008 03:02:38 GMT Oregon Health and Science University Cancer Institute scientists have observed that a tumor protein present in an aggressive form of breast cancer is correlation to a poor prognosis. The presence of the protein, called growth factor receptor-bound protein-7, often referred to as GRB-7, in breast cancer tumors, is strongly correlation to the growth and spread of the cancer, as per principal investigator Shiuh-Wen Luoh, M.D., Ph.D., assistant professor of medicine (hematology/medical oncology) in the OHSU School of Medicine........ ]]>